CancerMonthly.com
Title
Cancer Treatments / Therapy Results, Survival Rates, Toxicity, Side Effects, and Hospital information for 100s of therapies at Cancer Monthly
Description
Cancer Monthly was founded by volunteers whose lives were forever changed by cancer. When we needed treatment results, they were not available to us. Three years of time and considerable resources were invested so that Cancer Monthly would become a reality and that treatment result information would be available to other patients. While there are many sites that provide treatment options, this is the only resource that summarizes and reports on the actual results of these therapies. You should use this information to help make informed treatment decisions with your professional healthcare provider.
Today, Cancer Monthly is one of the fastest growing healthcare websites on the internet with over 10,000 visitors each week. Cancer Monthly's free e-newsletter, CancerWire has a separate readership of approximately 100,000 every month. Cancer Monthly has been written up by Smart Computing Magazine, Wired and has been the subject of over a dozen radio shows focusing on health.
The site is under the management and legal counsel of Michael Horwin, MA, JD. Mr. Horwin lost his son, Alexander, to brain cancer in 1999. Alexander's therapy was administered at a major children's hospital. After his death, the Horwins discovered that the treatment was not FDA approved for children or for brain cancer, that it was listed as a known human carcinogen, and that it had been considered a failure by other oncologists. Based on these revelations, Mr. Horwin was invited to testify before the U.S. Congress (Integrative Oncology: Cancer Care for the New Millennium June 7, 2000). In 2001, his expose War on Cancer won the Scribes Award for the best law article written in the United States. Mr. Horwin is a frequent guest of the Frankie Boyer show and Lifestyle Talk Radio which reaches 11 million households nationwide. Mr. Horwin's law practice is exclusively devoted to representing cancer patients.
